FDA Issues Warning Letter to Minnesota OTC Manufacturer

Drug Industry Daily
KEYWORDS FDA / Warning
A A

The FDA has issued a warning letter to Minnesota-based OTC drugmaker Diversified Manufacturing, accusing the company of violating current good manufacturing practices (cGMPs).

To View This Article:

Login

Subscribe To Drug Industry Daily